D.A. Mitchison
- Infectious Diseases top 0.05%
- Tuberculosis Research and Epidemiology 118
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 15
- Epidemiology top 0.2%
- Mycobacterium research and diagnosis 71
- Pneumocystis jirovecii pneumonia detection and treatment 23
- Pneumonia and Respiratory Infections 20
- Surgery top 1%
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 20
-
- Cancer therapeutics and mechanisms 20
- Phenothiazines and Benzothiazines Synthesis and Activities 15
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)The Lancet (5 papers)
- Partner nations
- United KingdomIndiaSouth Africa
In The Last Decade
D.A. Mitchison
155 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Infectious Diseases 6.2k
- Molecular Medicine 827
- Epidemiology 5.0k
- Surgery 2.1k
- Pharmacology 670
Countries citing papers authored by D.A. Mitchison
This map shows the geographic impact of D.A. Mitchison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A. Mitchison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A. Mitchison more than expected).
Fields of papers citing papers by D.A. Mitchison
This network shows the impact of papers produced by D.A. Mitchison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A. Mitchison. The network helps show where D.A. Mitchison may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D.A. Mitchison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hemagglutination Tests for Tuberculosis with Mycobacterial Glycolipid Antigens | 2015 | 0 |
| 2 | 2013 | 47 | |
| 3 | 2010 | 53 | |
| 4 | 2006 | 15 | |
| 5 | 2006 | 22 | |
| 6 | 2005 | 83 | |
| 7 | 2005 | 116 | |
| 8 | 2004 | 32 | |
| 9 | 2003 | 242 | |
| 10 | 1998 | 50 | |
| 11 | 1991 | 8 | |
| 12 | 1979 | 87 | |
| 13 | 1979 | 182 | |
| 14 | 1975 | 50 | |
| 15 | 1969 | 26 | |
| 16 | THE EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS. | 1964 | 44 |
| 17 | 1963 | 12 | |
| 18 | 1955 | 10 | |
| 19 | 1954 | 38 | |
| 20 | Discussion on Chemotherapy of Tuberculosis. | 1953 | 1 |
About D.A. Mitchison
D.A. Mitchison is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Pharmacology and Pharmacology, having authored 160 papers that have together received 7.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (118 papers), Mycobacterium research and diagnosis (71 papers), Pneumocystis jirovecii pneumonia detection and treatment (23 papers), Cancer therapeutics and mechanisms (20 papers), Pneumonia and Respiratory Infections (20 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers), Antibiotic Resistance in Bacteria (15 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (15 papers). The work is most often cited by research in Infectious Diseases (6.2k citations), Molecular Medicine (827 citations), Epidemiology (5.0k citations), Surgery (2.1k citations) and Pharmacology (670 citations). D.A. Mitchison has collaborated with scholars based in United Kingdom, India and South Africa. Frequent co-authors include Y Zhang, Jean M. Dickinson, Anthony Coates, J.B. Selkon, Wallace Fox, G Canetti, H Mahler, Yanmin Hu, Jasvir Dhillon and B.W. Allen. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, The Lancet, Journal of Clinical Pathology and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.